Zum weltweiten Stand der Hepatitis-B-Impfung 1998

Mark Kane

International Journal of Public Health, 1998, vol. 43, issue 1, S44-S46

Abstract: In 1991 WHO recommended that all countries include HB vaccine into their rcutine childhood ímmunization programmes. By 1998, more than 90 countríes have included HB vaccine as routine antigen in their national programmes. These countries include about half of the world's children and about 70% of the world's carriers. The WHO target is to prevent 80% of new HBV carriers in children by the year 2001 by adding the vaccine into routine immunization. The vaccine has proven to be 85% to 95% effective in preventíng the chronic carrier state in population based studies from many countries. Studies in Taiwan have already shown a direct reduction of liver cancer in immunized children. The major remaíning problem ís to develop financial mechanisms to allow the chíldren in the poorest countries to benefit from this important vaccine. Copyright Birkhäuser Verlag 1998

Date: 1998
References: Add references at CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://hdl.handle.net/10.1007/BF02042175 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:ijphth:v:43:y:1998:i:1:p:s44-s46

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/00038

DOI: 10.1007/BF02042175

Access Statistics for this article

International Journal of Public Health is currently edited by Thomas Kohlmann, Nino Künzli and Andrea Madarasova Geckova

More articles in International Journal of Public Health from Springer, Swiss School of Public Health (SSPH+)
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().